PML bodies: A meeting place for genomic loci?

Journal of Cell Science

Volumn 118, Issue 5, 2005, Pages 847-854

  Ching, Reagan W ^a   Dellaire, Graham ^a   Eskiw, Christopher H ^a   Bazett Jones, David P ^a  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

Author keywords

Chromatin; DNA replication; Gene transcription; PML body; Viral gene expression

Indexed keywords

LIGASE; PROMYELOCYTIC LEUKEMIA PROTEIN;

ARTICLE; CHROMATIN; DNA REPAIR; DNA REPLICATION; DNA VIRUS; ENZYME ACTIVITY; GENE EXPRESSION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN STABILITY; TRANSCRIPTION REGULATION; VIRUS DNA CELL DNA INTERACTION; VIRUS GENE;

ANIMALS; CELL CYCLE; CELL DIFFERENTIATION; CELL NUCLEUS; CHROMATIN; DNA VIRUSES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, VIRAL; HUMANS; INTRANUCLEAR INCLUSION BODIES; LEUKEMIA, PROMYELOCYTIC, ACUTE; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

DNA VIRUSES;

EID: 16844373902     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.01700     Document Type: Article

References (86)

1. Bazett-Jones, D. P. and Hendzel, M. J. (1999). Electron spectroscopic imaging of chromatin. Methods 17, 188-200.
2. Bernardi, R. and Pandolfi, P. P. (2003). Role of PML and the PML-nuclear body in the control of programmed cell death. Oncogene 22, 9048-9057.
3. Bischof, O., Kim, S. H., Irving, J., Beresten, S., Ellis, N. A. and Campisi, J. (2001). Regulation and localization of the Bloom syndrome protein in response to DNA damage. J. Cell. Biol. 153 367-380.
4. Bloch, D. B., de la Monte, S. M., Guigaouri, P., Filippov, A. and Bloch, K. D. (1996). Identification and characterization of a leukocyte-specific component of the nuclear body. J. Biol. Chem. 271, 29198-29204.
5. Bloch, D. B., Chiche, J. D., Orth, D., de la Monte, S. M., Rosenzweig, A. and Bloch, K. D. (1999). Structural and functional heterogeneity of nuclear bodies. Mol. Cell. Biol. 19, 4423-4430.
6. Bloch, D. B., Nakajima, A., Gulick, T., Chiche, J. D., Orth, D., de La Monte, S. M. and Bloch, K. D. (2000). Sp110 localizes to the PML-Sp100 nuclear body and may function as a nuclear hormone receptor transcriptional coactivator. Mol. Cell. Biol. 20, 6138-6146.
7. Boddy, M. N., Howe, K., Etkin, L. D., Solomon, E. and Freemont, P. S. (1996). PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia. Oncogene 13, 971-982.
8. Boisvert, F. M., Hendzel, M. J. and Bazett-Jones, D. P. (2000). Promyelocytic leukemia (PML) nuclear bodies are protein structures that do not accumulate RNA. J. Cell Biol. 148, 283-292.
9. Boisvert, F. M., Kruhlak, M. J., Box, A. K., Hendzel, M. J. and Bazett-Jones, D. P. (2001). The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia nuclear body. J. Cell Biol. 152, 1099-1106.
10. Boutell, C., Sadis, S. and Everett, R. D. (2002). Herpes simplex virus type 1 immediate-early protein ICP0 and is isolated RING finger domain act as ubiquitin E3 ligases in vitro. J. Virol. 76, 841-850.
11. Brown, K. E., Guest, S. S., Smale, S. T., Hahm, K., Merkenschlager, M. and Fisher, A. G. (1997). Association of transcriptionally silent genes with Ikaros complexes at centromeric heterochromatin. Cell 91, 845-854.
12. Burkham, J., Coen, D. M. and Weller, S. K. (1998). ND10 protein PML is recruited to herpes simplex virus type 1 prereplicative sites and replication compartments in the presence of viral DNA polymerase. J. Virol. 72, 10100-10107.
13. Burkham, J., Coen, D. M., Hwang, C. B. and Weller, S. K. (2001). Interactions of herpes simplex virus type 1 with ND10 and recruitment of PML to replication compartments. J. Virol. 75, 2353-2367.
14. Chee, A. V., Lopez, P., Pandolfi, P. P. and Roizman, B. (2003). Promyelocytic leukemia protein mediates interferon-based anti-herpes simplex virus 1 effects. J. Virol. 77, 7101-7105.
15. Chubb, J. R., Boyle, S., Perry, P. and Bickmore, W. A. (2002). Chromatin motion is constrained by association with nuclear compartments in human cells. Curr. Biol. 12, 439-445.
16. Cockerill, P. N. and Garrard, W. T. (1986). Chromosomal loop anchorage of the kappa immunoglobulin gene occurs next to the enhancer in a region containing topoisomerase II sites. Cell 44 273-282.
17. Csink, A. K. and Henikoff, S. (1996). Genetic modification of heterochromatic association and nuclear organization in Drosophila. Nature. 381, 529-531.
18. de Bruyn Kops, A. and Knipe, D. M. (1994). Preexisting nuclear architecture defines the intranuclear location of herpesvirus DNA replication structures. J. Virol. 68, 3512-3526.
19. Dellaire, G., Farrall, R. and Bickmore, W. A. (2003). The Nuclear Protein Database (NPD): sub-nuclear localization and functional annotation of the nuclear proteome. Nucleic Acids Res. 31, 328-330.
20. Dellaire, G. and Bazett-Jones, D. P. (2004). PML nuclear bodies: dynamic sensors of DNA damage and cellular stress. Bioessays 26, 963-977.
21. Dernburg, A. F., Broman, K. W., Fung, J. C., Marshall, W. F., Philips, J., Agard, D. A. and Sedat, J. W. (1996). Perturbation of nuclear architecture by long-distance chromosome interactions. Cell 85, 745-759.
22. de Stanchina, E., Querido, E., Narita, M., Davuluri, R. V., Pandolli, P. P., Ferbeyre, G. and Lowe, S. W. (2004). PML is a direct p53 target that modulates p53 effector functions. Mol Cell. 13, 523-535.
23. de Thé, H., Lavau, C., Marchio, A., Chomienne, C., Degos, L. and Dejean, A. (1991). The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66, 675-684.
24. D'Orazi, G., Cecchinelli, B., Bruno, T., Manni, I., Higashimoto, Y., Saito, S., Gostissa, M., Coen, S., Marchetti, A., Del Sal, G. et al. (2002). Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nat. Cell Biol. 4, 11-19.
25. Doucas, V., Ishov, A. M., Romo, A., Juguilon, H., Weitzman, M. D., Evans, R. M. and Maul, G. G. (1996). Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. Genes Dev. 10, 196-207.
26. Downes, M., Ordentlich, P., Kao, H. Y., Alvarez, J. G. and Evans, R. M. (2000). Identification of a nuclear domain with deacetylase activity. Proc. Natl. Acad. Sci. USA 97, 10330-10335.
27. Dyck, J. A., Maul, G. G., Miller, W. H., Jr, Chen, J. D., Kakizuka, A. and Evans, R. M. (1994). A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 76, 333-343.
28. Eskiw, C. H. and Bazett-Jones, D. P. (2002). The promyelocytic leukemia nuclear body: sites of activity? Biochem. Cell Biol. 80, 301-310.
29. Eskiw, C. H., Dellaire, G., Mymryk, J. S. and Bazett-Jones, D. P. (2003). Size, position and dynamic behavior of PML nuclear bodies following cell stress as a paradigm for supramolecular trafficking and assembly. J. Cell Sci. 116, 4455-4466.
30. Eskiw, C. H., Dellaire, G. and Bazett-Jones, D. P. (2004). Chromatin contributes to structural integrity of promyelocytic leukemia bodies through a SUMO-1-independent mechanism. J. Biol. Chem. 279, 9577-9585.
31. Everett, R. D. and Zafiropoulos, A. (2004). Visualization by live-cell microscopy of disruption of ND10 during herpes simplex virus type 1 infection. J. Virol. 78, 11411-11415.
32. Everett, R. D., Freemont, P., Saitoh, H., Dasso, M., Orr, A., Kathoria, M. and Parkinson, J. (1998). The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110-and proteasome-dependent loss of several PML isoforms. J. Virol. 72 6581-6591.
33. Everett, R. D., Earnshaw, W. C., Pluta, A. F., Sternsdorf, T., Ainsztein, A. M., Carmena, M., Ruchaud, S., Hsu, W. L. and Orr, A. (1999). A dynamic connection between centromeres and ND10 proteins. J. Cell Sci. 112, 3443-3454.
34. Everett, R. D., Sourvinos, G. and Orr, A. (2003). Recruitment of herpes simplex virus type 1 transcriptional regulatory protein ICP4 into foci juxtaposed to ND10 in live, infected cells. J. Virol. 77, 3680-3689.
35. Everett, R. D., Sourvinos, G., Leiper, C., Clements, J. B. and Orr, A. (2004). Formation of nuclear foci of the herpes simplex virus type 1 regulatory protein ICP4 at early times of infection: localization, dynamics, recruitment of ICP27, and evidence for the de novo induction of ND10-like complexes. J. Virol. 78, 1903-1917.
36. Fogal, V., Gostissa, M., Sandy, P., Zacchi, P., Sternsdorf, T., Jensen, K., Pandolfi, P. P., Will, H., Schneider, C. and Del Sal, G. (2000). Regulation of p53 activity in nuclear bodies by a specific PML isoform. EMBO J. 19, 6185-6195.
37. Fridman, J. S. and Lowe, S. W. (2003). Control of apoptosis by p53. Oncogene 22, 9030-9040.
38. Goddard, A. D., Borrow, J., Freemont, P. S. and Solomon, E. (1991). Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science 254, 1371-1374.
39. Grande, M. A., van der Kraan, I., van Steensel, B., Schul, W., de The, H., van der Voort, H. T., de Jong, L. and van Driel, R. (1996). PML-containing nuclear bodies: their spatial distribution in relation to other nuclear components. J. Cell Biochem. 63, 280-291.
40. Hofmann, T. G., Moller, A., Sirma, H., Zentgraf, H., Taya, Y., Droge, W., Will, H. and Schmitz, M. L. (2002). Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat. Cell Biol. 4, 1-10.
41. Huang, S. and Spector, D. L. (1991). Nascent pre-mRNA transcripts are associated with nuclear regions enriched in splicing factors. Genes Dev. 5, 2288-2302.
42. Ishov, A. M. and Maul, G. G. (1996). The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition. J. Cell Biol. 134, 815-826.
43. Ishov, A. M., Stenberg, R. M. and Maul, G. G. (1997). Human cytomegalovirus immediate early interaction with host nuclear structures: definition of an immediate transcript environment. J. Cell Biol. 138, 5-16.
44. Ishov, A. M., Sotnikov, A. G., Negorev, D., Vladimirova, O. V., Neff, N., Kamitani, T., Yeh, E. T., Strauss, J. F., 3rd and Maul, G. G. (1999). PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J. Cell Biol. 147, 221-234.
45. Ishov, A. M., Vladimirova, O. V. and Maul, G. G. (2002). Daxx-mediated accumulation of human cytomegalovirus tegument protein pp71 at ND10 facilitates initiation of viral infection at these nuclear domains. J. Virol. 76, 7705-7712.
46. Kakizuka, A., Miller, W. H., Jr, Umesono, K., Warrell, R. P., Jr, Frankel, S. R., Murty, V. V., Dmitrovsky, E. and Evans, R. M. (1991). Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 66, 663-674.
47. Koken, M. H., Puvion-Dutilleul, E., Guillemin, M. C., Viron, A., Linares-Cruz, G., Stuurman, N., de Jong, L., Szostecki, C., Calvo, F. and Chomienne, C. (1994). The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J. 13 1073-1083.
48. Korioth, F., Maul, G. G., Plachter, B., Stamminger, T. and Frey, J. (1996). The nuclear domain 10 (ND10) is disrupted by the human cytomegalovirus gene product IE1. Exp. Cell Res. 229, 155-158.
49. Kruhlak, M. J., Lever, M. A., Fischle, W., Verdin, E., Bazett-Jones, D. P. and Hendzel, M. J. (2000). Reduced mobility of the alternate splicing factor (ASF) through the nucleoplasm and steady state speckle compartments. J. Cell Biol. 150, 41-51.
50. Kurki, S., Latonen, L. and Laiho, M. (2003). Cellular stress and DNA damage invoke temporally distinct Mdm2, p53 and PML complexes and damage-specific nuclear relocalization. J. Cell Sci. 116, 3917-3925.
51. Lafarga, M., Berciano, M. T., Pena, E., Mayo, I., Castano, J. G., Bohmann, D., Rodrigues, J. P., Tavanez, J. P. and Carmo-Fonseca, M. (2002). Clastosome: a subtype of nuclear body enriched in 19S and 20S proteasomes, ubiquitin, and protein substrates of proteasome. Mol. Biol. Cell 13, 2771-2782.
52. Lallemand-Breitenbach, V., Zhu, J., Puvion, F., Koken, M., Honore, N., Doubeikovsky, A., Duprez, E., Pandolfi, P. P., Puvion, E., Freemont, P. et al. (2001). Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation. J. Exp. Med. 193, 1361-1371.
53. LaMorte, V. J., Dyck, J. A., Ochs, R. L. and Evans, R. M. (1998). Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body. Proc. Natl. Acad. Sci. USA. 95, 4991-4996.
54. Lombard, D. B. and Guarente, L. (2000). Nijmegen breakage syndrome disease protein and MRE11 at PML nuclear bodies and meiotic telomeres. Cancer Res. 60, 2331-2334.
55. Malone, C. L., Vesole, D. H. and Stinski, M. F. (1990). Transactivation of a human cytomegalovirus early promoter by gene products from the immediate-early gene IE2 and augmentation by IE1: mutational analysis of the viral proteins. J. Virol. 64, 1498-1506.
56. Maul, G. G. and Everett, R. D. (1994). The nuclear location of PML, a cellular member of the C3HC4 zinc-binding domain protein family, is rearranged during herpes simplex virus infection by the C3HC4 viral protein ICP0. J. Gen. Virol. 75, 1223-1233.
57. Maul, G. G., Yu, E., Ishov, A. M. and Epstein, A. L. (1995). Nuclear domain 10 (ND10) associated proteins are also present in nuclear bodies and redistribute to hundreds of nuclear sites after stress. J. Cell Biochem. 59, 498-513.
58. Maul, G. G., Ishov, A. M. and Everett, R. D. (1996). Nuclear domain 10 as preexisting potential replication start sites of herpes simplex virus type-1. Virology 217, 67-75.
59. Melnick, A. and Licht, J. D. (1999). Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93, 3167-3215.
60. 2+ exposure regulate PML and Daxx release from ND10 by independent mechanisms that modify the induction of heat-shock proteins 70 and 25 differently. J. Cell Sci. 116, 513-524.
61. Negorev, D. and Maul, G. G. (2001). Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot. Oncogene 20, 7234-7242.
62. Pearson, M., Carbone, R., Sebastiani, C., Cioce, M., Fagioli, M., Saito, S., Higashimoto, Y., Appella, E., Minucci, S., Pandolfi, P. P. et al. (2000). PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 406, 207-210.
63. Pederson, T. (1998). Thinking about a nuclear matrix. J. Mol. Biol. 277, 147-159.
64. Platani, M., Goldberg, I., Lamond, A. I. and Swedlow, J. R. (2002). Cajal body dynamics and association with chromatin are ATP-dependent. Nat. Cell Biol. 4, 502-508.
65. Prives, C. (1998). Signaling to p53: breaking the MDM2-p53 circuit. Cell 95, 5-8.
66. Regad, T. and Chelbi-Alix, M. K. (2001). Role and fate of PML nuclear bodies in response to interferon and viral infections. Oncogene 20, 7274-7286.
67. Salomoni, P. and Pandolfi, P. P. (2002). The role of PMI in tumor suppression. Cell 108, 165-170.
68. Sanz, M. M., Proytcheva, M., Ellis, N. A., Holloman, W. K. and German, J. (2000). BLM, the Bloom's syndrome protein, varies during the cell cycle in its amount, distribution, and co-localization with other nuclear proteins. Cytogenet. Cell Genet. 91, 217-223.
69. Shav-Tal, Y., Darzacq, X., Shenoy, S. M., Fusco, D., Janicki, S. M., Spector, D. L. and Singer, R. H. (2004). Dynamics of single mRNPs in nuclei of living cells. Science 304, 1797-1800.
70. Shiels, C., Islam, S. A., Vatcheva, R., Sasieni, P., Sternberg, M. J., Freemont, P. S. and Sheer, D. (2001). PML bodies associate specifically with the MHC gene cluster in interphase nuclei. J. Cell Sci. 114, 3705-3716.
71. Sourvinos, G. and Everett, R. D. (2002). Visualization of parental HSV-1 genomes and replication compartments in association with ND10 in live infected cells. EMBO J. 21, 4989-4997.
72. Stenberg, R. M., Fortney, J., Barlow, S. W., Magrane, B. P., Nelson, J. A. and Ghazal, P. (1990). Promoter-specific trans activation and repression by human cytomegalovirus immediate-early proteins involves common and unique protein domains. J. Virol. 64, 1556-1565.
73. Sun, Y., Durrin, L. K. and Krontiris, T. G. (2003). Specific interaction of PML bodies with the TP53 locus in Jurkat interphase nuclei. Genomics 82, 250-252.
74. Szostecki, C., Guldner, H. H., Netter, H. J. and Will, H. (1990). Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients wiLh primary biliary cirrhosis. J. Immunol. 145, 4338-4347.
75. Takahashi, Y., Lallemand-Breitenbach, V., Zhu, J. and de Thé. H. (2004). PML nuclear bodies and apoptosis. Oncogene 23, 2819-2824.
76. Tang, Q., Bell, P., Tegtmeyer, P. and Maul, G. G. (2000). Replication but not transcription of simian virus 40 DNA is dependent on nuclear domain 10. J. Virol. 74, 9694-9700.
77. Tang, Q., Li, L., Ishov, A. M., Revol, V., Epstein, A. L. and Maul, G. G. (2003). Determination of minimum herpes simplex virus type 1 components necessary to localize transcriptionally active DNA to ND10. J. Virol. 77, 5821-5828.
78. Tsukamoto, T., Hashiguchi, N., Janicki, S. M., Tumbar, T., Belmont, A. S. and Spector, D. L. (2000). Visualization of gene activity in living cells. Nat. Cell Biol. 2, 871-878.
79. Van Sant, C., Hagglund, R., Lopez, P. and Roizman, B. (2001). The infected cell protein 0 of herpes simplex virus 1 dynamically interacts with proteasomes, binds and activates the cdc34 E2 ubiquitin-conjugating enzyme, and possesses in vitro E3 ubiquitin ligase activity. Proc. Natl. Acad. Sci. USA 98, 8815-8820.
80. Wang, J., Shiels, C., Sasieni, P., Wu, P. J., Islam, S. A., Freemont, P. S. and Sheer, D. (2004). Promyelocytic leukemia nuclear bodies associate with transcriptionally active genomic regions. J. Cell Biol. 164, 515-526.
81. Weis, K., Rambaud, S., Lavau, C., Jansen, J., Carvalho, T., Carmo-Fonseca, M., Lamond, A. and Dejean, A. (1994). Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells. Cell 76, 345-356.
82. Wiesmeijer, K., Molenaar, C., Bekeer, I. M., Tanke, H. J. and Dirks, R. W. (2002). Mobile foci of Sp100 do not contain PML: PML bodies are immobile but PML and Sp100 proteins are not. J. Struct. Biol. 140, 180-188.
83. Willis, S., Day, C. L., Hinds, M. G. and Huang, D. C. (2003).The Bcl-2-regulated apoptotic pathway. J. Cell Sci. 116 4053-4056.
84. Wu, G., Lee, W. H. and Chen, P. L. (2000). NBS1 and TRF1 colocalize at promyelocytic leukemia bodies during late S/G2 phases in immortalized telomerase-negative cells. Implication of NBS1 in alternative lengthening of telomeres. J. Biol. Chem. 275, 30618-30622.
85. Yeager, T. R., Neumann, A. A., Englezou, A., Huschtscha, L. I., Noble, J. R. and Reddel, R. R. (1999). Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res. 59, 4175-4179.
86. Zhong, S., Salomoni, P. and Pandolfi, P. P. (2000). The transcriptional role of PML and the nuclear body. Nat. Cell Biol. 2, E85-E90.